Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pheon Therapeutics
Eli Lilly and Company
Teclison Ltd.
M.D. Anderson Cancer Center
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Zymeworks BC Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Montefiore Medical Center
Montefiore Medical Center
National Cancer Institute (NCI)
Travera Inc
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Bristol-Myers Squibb
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Pfizer
Fred Hutchinson Cancer Center
Revolution Medicines, Inc.
AstraZeneca
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Cancer Research UK
Turning Point Therapeutics, Inc.
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
Conjupro Biotherapeutics, Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
Abramson Cancer Center at Penn Medicine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Avera McKennan Hospital & University Health Center
Hoffmann-La Roche
City of Hope Medical Center
National Cancer Institute (NCI)
SystImmune Inc.
Pfizer
Institut Paoli-Calmettes
Brigham and Women's Hospital
RasCal Therapeutics, Inc.
Novartis
Frontier Medicines Corporation